(MedPage Today) — At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for patients with previously untreated follicular lymphoma with a high tumor burden.
In this MedPage Today…
Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearls/119131
Author :
Publish date : 2025-12-22 17:08:00
Copyright for syndicated content belongs to the linked Source.
